In prostate cancer cells with TRABID overexpression, however, high-level expression of TRABID overrides SPOP-mediated 53BP1 polyubiquitination, which consequently prolongs 53BP1 retention at DSB sites and inhibits HR activity. Here, ZRANB1 is linked to prostate carcinoma.